Highlights from EBMT 2016: Immunotherapy

Arnon Nagler, MD, from Sheba Medical Center, Tel Hashomer, Israel, discusses why immunotherapy is his highlight from the 2016 Annual Meeting of the European Society for Blood and Marrow Transplantation (EBMT), held in Valencia, Spain. Prof Nagler explains the importance of chemotherapy in clinical practice at the moment but also, that it is a very crude treatment. Then he discusses the new developments in immunotherapy, such as monoclonal antibodies and chimeric antigen receptors (CARs) and their promise for the future of cancer therapy.